Central African Republic

Sentinel surveillance of the WHO-Validated Pfkelch13 C580Y Artemisinin Resistance Marker in Plasmodium falciparum Isolates from Bangui, Central African Republic

Moynam Ekte Heredeibona, Aroun Abdel Nassir, Bejendo Dan-Houron, Héritier Obed Lango, Christelle Luce Bobossi, Coretha Bokia Baguida, Ernest Lango-Yaya, Boniface Koffi, Emile Minyaka & Romaric NzoumbouBoko · Microbiology Research Journal International · 2026

Background: Artemisinin-based combination therapies (ACTs) are the cornerstone of malaria treatment. However, partial artemisinin resistance associated with mutations in the Plasmodium falciparum Pfkelch13 propeller domain threatens malaria control efforts. The C580Y substitution...

Open access Research Article 10.9734/mrji/2026/v36i61751

Epidemiological, Therapeutic, and Molecular Challenges of HIV in the Central African Republic: A Literature Review

Laris Michael Dan-Houron Bejendo, Héritier Lango, Clotaire Donatien Rafaï, Wanh-Ingo Hereidebona, Christelle Bobossi, Coreta Baguida Bokia, Moynam Heredeibona, Boniface Koffi & Ernest Lango-Yaya · Microbiology Research Journal International · 2026

Background: Human immunodeficiency virus (HIV) remains a major public health challenge in sub-Saharan Africa. The Central African Republic (CAR) is characterized by a generalized epidemic with persistently high prevalence, ongoing transmission, and significant structural health s...

Open access Research Article 10.9734/mrji/2026/v36i51748